1. Home
  2. OLMA vs CMP Comparison

OLMA vs CMP Comparison

Compare OLMA & CMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OLMA
  • CMP
  • Stock Information
  • Founded
  • OLMA 2006
  • CMP 1993
  • Country
  • OLMA United States
  • CMP United States
  • Employees
  • OLMA N/A
  • CMP N/A
  • Industry
  • OLMA Biotechnology: Pharmaceutical Preparations
  • CMP Other Metals and Minerals
  • Sector
  • OLMA Health Care
  • CMP Basic Materials
  • Exchange
  • OLMA Nasdaq
  • CMP Nasdaq
  • Market Cap
  • OLMA 725.5M
  • CMP 781.2M
  • IPO Year
  • OLMA 2020
  • CMP 2003
  • Fundamental
  • Price
  • OLMA $8.48
  • CMP $17.16
  • Analyst Decision
  • OLMA Strong Buy
  • CMP Hold
  • Analyst Count
  • OLMA 6
  • CMP 3
  • Target Price
  • OLMA $23.00
  • CMP $20.00
  • AVG Volume (30 Days)
  • OLMA 969.7K
  • CMP 367.4K
  • Earning Date
  • OLMA 11-10-2025
  • CMP 12-08-2025
  • Dividend Yield
  • OLMA N/A
  • CMP N/A
  • EPS Growth
  • OLMA N/A
  • CMP N/A
  • EPS
  • OLMA N/A
  • CMP N/A
  • Revenue
  • OLMA N/A
  • CMP $1,225,200,000.00
  • Revenue This Year
  • OLMA N/A
  • CMP $12.05
  • Revenue Next Year
  • OLMA N/A
  • CMP $4.15
  • P/E Ratio
  • OLMA N/A
  • CMP N/A
  • Revenue Growth
  • OLMA N/A
  • CMP 7.27
  • 52 Week Low
  • OLMA $2.86
  • CMP $8.60
  • 52 Week High
  • OLMA $11.54
  • CMP $22.69
  • Technical
  • Relative Strength Index (RSI)
  • OLMA 49.32
  • CMP 43.46
  • Support Level
  • OLMA $7.82
  • CMP $16.40
  • Resistance Level
  • OLMA $8.80
  • CMP $18.84
  • Average True Range (ATR)
  • OLMA 0.61
  • CMP 0.68
  • MACD
  • OLMA -0.02
  • CMP 0.08
  • Stochastic Oscillator
  • OLMA 41.57
  • CMP 31.49

About OLMA Olema Pharmaceuticals Inc.

Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.

About CMP Compass Minerals Intl Inc

Compass Minerals currently produces two primary products: salt and specialty potash fertilizer. The company's main assets include rock salt mines in Ontario, Louisiana, and the United Kingdom. The fertilizer is produced from a brine operation at the Great Salt Lake in Utah that produces sulfate of potash and magnesium chloride. Compass' salt products are used for deicing and also by industrial and consumer end markets. The firm's sulfate of potash is used by growers of high-value crops that are sensitive to standard potash.

Share on Social Networks: